Nuveen Asset Management’s Allogene Therapeutics ALLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
$641K Buy
300,871
+46,632
+18% +$99.3K ﹤0.01% 2893
2024
Q3
$712K Buy
254,239
+15,170
+6% +$42.5K ﹤0.01% 2891
2024
Q2
$557K Sell
239,069
-63,186
-21% -$147K ﹤0.01% 2950
2024
Q1
$1.35M Sell
302,255
-55,303
-15% -$247K ﹤0.01% 2575
2023
Q4
$1.15M Sell
357,558
-2,643
-0.7% -$8.48K ﹤0.01% 2672
2023
Q3
$1.14M Buy
360,201
+23,337
+7% +$74K ﹤0.01% 2524
2023
Q2
$1.67M Buy
336,864
+63,186
+23% +$314K ﹤0.01% 2422
2023
Q1
$1.35M Buy
273,678
+56,329
+26% +$278K ﹤0.01% 2493
2022
Q4
$1.37M Sell
217,349
-129,820
-37% -$816K ﹤0.01% 2548
2022
Q3
$3.75M Sell
347,169
-227,183
-40% -$2.45M ﹤0.01% 2060
2022
Q2
$6.55M Sell
574,352
-105,469
-16% -$1.2M ﹤0.01% 1774
2022
Q1
$6.45M Buy
679,821
+338,767
+99% +$3.22M ﹤0.01% 1921
2021
Q4
$5.09M Sell
341,054
-104,476
-23% -$1.56M ﹤0.01% 2098
2021
Q3
$11.5M Sell
445,530
-128,074
-22% -$3.29M ﹤0.01% 1686
2021
Q2
$15M Buy
573,604
+345,555
+152% +$9.01M ﹤0.01% 1596
2021
Q1
$8.05M Sell
228,049
-7,316
-3% -$258K ﹤0.01% 1915
2020
Q4
$5.94M Sell
235,365
-118,130
-33% -$2.98M ﹤0.01% 1980
2020
Q3
$13.3M Sell
353,495
-10,374
-3% -$391K 0.01% 1327
2020
Q2
$15.6M Buy
363,869
+211,485
+139% +$9.06M 0.01% 1196
2020
Q1
$2.96M Buy
152,384
+1,589
+1% +$30.9K ﹤0.01% 1991
2019
Q4
$3.92M Sell
150,795
-422,232
-74% -$11M ﹤0.01% 2119
2019
Q3
$15.6M Buy
573,027
+15,595
+3% +$425K 0.01% 1289
2019
Q2
$15M Buy
+557,432
New +$15M 0.01% 1339